COMPANY PROFILE

SuperDimension

Explore full profile

Minimally invasive pulmonology devices enabling diagnosis and treatment of deep-lung lesions

Plymouth, United StatesFounded 1995Biotech & Life Sciences

Valuation $250–500M Last recorded · 2012

Total funding $50–100M Disclosed equity funding

Unlock exact values

About SuperDimension

SuperDimension, a subsidiary of Medtronic, operates in the medical technology sector, providing advanced tools and resources to healthcare professionals. The company focuses on delivering high-quality, integrated, and cost-effective care solutions. SuperDimension serves a wide range of clients, including hospitals, clinics, and individual healthcare providers. The company operates in the global healthcare market, leveraging its expertise to address some of the most pressing challenges in patient care. SuperDimension's business model revolves around the development and sale of medical devices and solutions, generating revenue through product sales and service contracts. By continuously innovating and collaborating with industry experts, SuperDimension aims to improve patient outcomes and support the healthcare community.

MoreLess Source: Dealroom company data

At a glance

Status: Acquired
Founded: 1995
Headquarters: Plymouth, United States
Open positions: None listed
Dealroom signal: 25.0/100
Industry: Health
Sub-industry: BioTechnology
Sector: Biotech & Life Sciences, Biotechnology, Biotech and Pharma, Hard Tech, DT and LS, science-based
Business model: Manufacturing
Client focus: b2b
Links: Website

Knowledge graph

Founder mafia, market maps, research and news connected to this company by Dealroom

Funding history

6 recorded events

Company financing events and reported valuations.

Deal type	Date	Amount	Valuation	Investors	Source
ACQUISITIONOther financing	Mar 2012	$300M	$300M	Covidien	—
EARLY VCOther financing	Sep 2011	$11M	$44M	Covidien Ventures	—

Showing the latest 2 of 6 recorded eventsBook a demo for the full funding history →

Growth signals

SuperDimension website traffic

Latest recorded traffic for SuperDimension is 0 monthly website visits.

Latest monthly visits0

Monthly website visitsApr 2016–May 2020

Explore monthly traffic historyTrack growth over time and compare with peersBook a demo

Summary metrics are public; monthly history is available with a demoCompare with peers →

Similar companies

Closest operating peers by Dealroom taxonomy

Company identity and context are open; selected comparison metrics preview what is available on the platform.

Company	Headquarters	Status	Employees	Total funding	Valuation
VOVodorasloYour solution to better air quality	Sofia, Bulgaria	Operational	1	$61K	$132K
NBNormax BiomedNormax focus for 2022 is rapid growth in mRNA Vaccine R&D and manufacturing for sustainable pandemic preparedness	Cork, Ireland	Operational
ETENSEM TherapeuticsBiotechnology company focusing on high value and difficult-to-drug oncology targets	Medford, United States	Operational
LTLTZ TherapeuticsDevelops novel immunotherapies to treat patients that suffer from cancer and other diseases with an unmet clinical need	Redwood City, United States	Operational
ATAtG TherapeuticsAt AtG, we develop novel classes of medicines and biomarkers to prevent cancer therapeutic resistance	L'Hospitalet de Llobregat, Spain	Operational
TTTeitur TrophicsCyclic peptide therapeutics for neurodegenerative diseases	Aarhus, Denmark	Operational
RPRivus PharmaceuticalsOperates as a biopharmaceutical company dedicated to improving cardio-metabolic health	Charlottesville, United States	Operational
KTKintsugi TherapeuticsDevelopment of ER stress inhibitors for the treatment of metabolic diseases	Barcelona, Spain	Operational